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Introduction
In our hematopoieteic stem cell transplantation (HSCT)
center, preventation of invasive fungal diseases (IFDs)
for the patients who did not experience IFDs previously
is based on performing allogeneic SCT in rooms with
“High efficiency particulate air” (HEPA) filters and
administration of fluconazole prophylaxis.
Objectives
We aimed to evaluate our prophylaxis policy to ensure if
preventive measures are working.
Methods
Erciyes University Hospital is a 1300-bed tertiary centre
with a 38-bed HSCT center. We retrospectively
reviewed records of 146 ASCT episodes between Janu-
ary 2012 and December 2014 to detect the patients with
IFDs before engraftment. Patients who experince IFDs
before ASCT were excluded from the study. As flucona-
zole has no activity against Aspergillus spp, an early
diagnostic policy for invasive aspergillosis (IA) was
guided by twice weekly Aspergillus Galactomannan anti-
gen detection from the day of neutropenia until engraft-
ment and radiological interventions when clinically
required. The European Organization for Research and
Treatment of Cancer and the Mycoses Study Group cri-
teria were used to categorize the patients as having proven,
probable, or possible IA. IA is accepted as nosocomial if
patient was hospitalized more than seven days and no his-
tory of previous IFDs in the last six months.
Results
The 105 out of 146 ASCT episodes were from matched
related donor, 10 were from matched unrelated donor,
and 31 were haploidentical ASCT. Possible IA was diag-
nosed in 10 patients, probable IA was diagnosed in 3
patients, proven IA in 1 patient, and fungemia was
detected in 4 patients. Candida mucositis was diagnosed
in 7 patients. The crude mortality rate in three months
after ASCT was 10.4% (4 patients with IFDs vs 11
patients without IFDs) in 144 ASCT patients who were
followed by our center.
Conclusion
ASCT in rooms with HEPA filters with positive pres-
sure, combined with fluconazole prophylaxis prevented
IFDs in 82.8% of the 146 ASCT episodes in pre-engraft-
ment period.
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